Exparel and Dexamethasone
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorDuke University
About this trial
This prospective randomized clinical trial evaluates the duration of sensory blockade in patients undergoing shoulder surgery receiving interscalene brachial plexus blocks with either liposomal bupivacaine alone or liposomal bupivacaine combined with dexamethasone.
Eligibility criteria
Qualifiers
Adults aged 18 to 80 years
ASA physical status 1-3
Undergoing primary shoulder surgery with interscalene nerve block
Disqualifiers
ASA 4 or 5
Revision shoulder surgery
Daily chronic opioid use (over 3 months of continuous opioid use)
Inability to communicate pain scores or need for analgesia
Trial design
Treatments tested in this trial
- Liposomal Bupivacaine with Bupivacaine
- Dexamethasone
Treatment groups
80 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov